Dr Federico Cappuzzo, MD

Director of Oncology and Hematology Department, AUSL della Romagna-Ravenna, Italy

Institute: Director of Oncology and Hematology Department, AUSL della Romagna-Ravenna, Italy

Dr Federico Cappuzzo has been the Director of Medical Oncology at AUSL della Romagna-Ravenna since 2016. Dr Cappuzzo has been the Director on Hematology and Oncology Department since 2017.

In 1992, Dr Cappuzzo graduated, summa cum laude, from Palermo University with a degree in Medicine and Surgery. In 1996, Dr Cappuzzo completed a degree, summa cum laude, in Medical Oncology from the Milan University and gained a certification in Medical Oncology from the European Society for Medical Oncology (ESMO).

From 1997 to 1999 Dr Cappuzzo was the recipient of an ESMO Fellowship on Gene Therapy of Lung Cancer at Institut Gustave Roussy in Villejuif (Paris). In 2000, Dr Cappuzzo worked in the thoracic oncology unit at Medical University of South Carolina in Charleston (USA).

From 2000 to 2006, Dr Cappuzzo was Assistant Professor at Ospedale Bellaria in Bologna, and for four years was Assistant Professor of Medical Oncology at Istituto Clinico Humanitas IRCCS in Rozzano (Milano). Dr Cappuzzo acted as visiting associate professor at the University of Colorado in Denver (USA) in 2004. For six years Dr Cappuzzo was the Director of Medical Oncology Department at the Istituto Toscano Tumori-Ospedale Civile in Livorno.

Dr Cappuzzo is a member of the Italian Association in Medical Oncology (AIOM), European

Society for Medical Oncology (ESMO), American Society Clinical Oncology (ASCO) and

International Association for the Study of Lung Cancer (IASCL). Dr Cappuzzois is also a Member of the editorial board of Lung Cancer and has been the Chairman of the Educational Committee of IASLC since 2006.

Dr Cappuzzo received grants from the Italian Association for Cancer Research (AIRC) on targeted therapies in lung cancer in 2006, 2009 and 2012. Dr Cappuzzo has authored more than 200 papers in peer-review journals, mainly in translational research in lung cancer.